AVALYN PHARMA INC

AVLN · NASDAQ

Updated at 2026-10-15 11:19:34

$23.69-0.21%
Today's High
$24.14
Today’s Low
$22.68
AVALYN PHARMA INC (AVLN) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$23.69
Previous Close
$23.69
Volume
267.77K
Market Cap
$1.05B
P/E Ratio
--
EPS
--

Previous Day Range

$22.68$24.14

52-Week Range

$23.07$40.17

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
BIOTECHNOLOGY
Headquarters
105 W FIRST STREET, BOSTON, MA, UNITED STATES, 02127
Country
US
Listing Date
2026-04-30
Fiscal Year End
December
Shares Outstanding
44.33M
CIK
--

Avalyn Pharma Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for severe respiratory diseases, with its lead candidate, AV-101, specifically targeting the underlying causes of lung inflammation and fibrosis. The company addresses critical unmet medical needs in respiratory health through a robust pipeline and a commitment to next-generation treatment solutions. With an experienced leadership team and a distinguished scientific advisory board, Avalyn is strategically positioned to enhance patient outcomes and capture an expanding market in respiratory therapeutics.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-06-30

$0

2025-03-31

$0

Operating Expenses

2026-06-30

$31.18M

2026-03-31

$27.9M

2025-06-30

$21.77M

2025-03-31

$18.71M

Net Income

2026-06-30

-$28.93M

2026-03-31

-$26.86M

2025-06-30

-$20.19M

2025-03-31

-$17.5M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-06-30

--

2025-03-31

--

Earnings Per Share

2026-06-30

$-0.98

2026-03-31

$-21.83

2025-06-30

--

2025-03-31

--

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$31.18M

2026-03-31

-$26.7M

2025-06-30

-$20.18M

2025-03-31

-$17.49M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-06-30

--

2025-03-31

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.